Loading organizations...
Loading organizations...
Developing novel fusion proteins for chronic pain treatment.
Synerkine Pharma has raised $7.7M across 2 funding rounds.
Synerkine Pharma has raised $7.7M in total across 2 funding rounds.
Synerkine Pharma has raised $7.7M in total across 2 funding rounds.
Synerkine Pharma's investors include Ted Fjällman, Thuja Capital, Utrecht Holdings.
Synerkine Pharma has raised $7.7M across 2 funding rounds. Most recently, it raised $4.0M Series A Extension in December 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 16, 2021 | $4.0M Series A Extension | Ted Fjällman | Thuja Capital, Utrecht Holdings |
| Mar 25, 2019 | $3.7M Series A | Thuja Capital |